Receive report status and quick access to patient information /// EXPLORE NOW Tempus One: New AI Clinical Assistant Available for All Providers



Filter By
  • image description

    Evidence & guidelines-based application of PGx in mental health

    Learn how evidence and guidelines-based pharmacogenomics (PGx) can be a useful tool to inform medication selection and dosing in psychiatry.

    Speakers: Dr. Jon Durrani
    Practicing Neurologist, Dayton Center for Neurological Disorders

    Dr. Muneer Ali
    Child, Adolescent and Adult Psychiatrist & Senior Director of Medical Affairs, Neuro/Psychiatry, Tempus

    Watch replay
  • image description

    The evolving landscape in precision oncology: key research findings from the 2023 ASCO Annual Meeting

    Hear from Tempus moderators Dr. Ezra Cohen and Dr. Calvin Chao as they engage in a multi-disciplinary discussion around practice changing approaches to somatic and germline testing with Dr. Ramaswamy Govindan from Siteman Cancer Center and Dr. Cathy Handy Marshall from Johns Hopkins Medicine.

    Speakers: Ezra Cohen, MD
    Chief Medical Officer of Oncology, Tempus

    Calvin Chao, MD
    Senior Vice President of Medical Affairs, Tempus

    Dr. Ramaswamy Govindan
    Professor of Medicine, Washington University in St. Louis, Siteman Cancer Center

    Catherine Handy Marshall, MD, MPH
    Assistant Professor of Oncology, Johns Hopkins Medicine

    Watch replay
  • image description

    An analysis on the utility of liquid biopsy (LBx) throughout clinical development

    Listen to industry leaders discuss longitudinal endpoints for disease progression, the evolving role of liquid biopsy within drug development, and the value of methylation in combination with liquid biopsy.

    Speakers: Nike Beaubier, MD
    Senior Vice President, Life Science Pathology, Tempus

    Ezra Cohen, MD
    Chief Medical Officer of Oncology, Tempus

    Michael Yasiejko
    General Manager and Executive Vice President, Tempus

    Watch replay
  • image description

    Accelerate clinical trial enrollment and site activation

    Learn how TriHealth uses the TIME network to identify trial subjects and rapidly activate new clinical trials within its oncology portfolio within an average of ~10 business days.

    Speakers: Amy Gordon Franzen
    SVP, Trials Business, Tempus

    James F Maher, MD
    Oncologist, TriHealth

    Jason Claes, MBA, MSM, GRCRA
    Clinical Research Manager, TriHealth

    Watch replay
  • image description

    Tempus’ FDA approval and insights on the use of companion diagnostics in clinical development

    Tempus has recently announced the PMA approval for xT CDx, our solid tumor CDx and 648 gene panel.

    Speakers: Elaine Katrivanos
    VP, Regulatory Affairs, Tempus

    Lauren Silvis
    SVP, External Affairs, Tempus

    Kate Sasser
    Chief Scientific Officer, Tempus

    Watch replay
  • image description

    NGS in advanced breast cancer: exploring recent clinical advancements

    Learn more about breast cancer management with NGS. We explore the potential utility of complementary solid tumor and liquid biopsy testing in informing treatment decisions, as well as patient management strategies in the post CDK4/6 inhibitor therapy setting.

    Speakers: Calvin Chao, MD
    SVP of Medical Affairs, Tempus

    Cynthia Ma, MD, PhD
    Professor of Medicine, Washington University in St. Louis, Siteman Cancer Center

    Massimo Cristofanilli, MD, FACP
    Chief, Breast Medical Oncology, Sandra Edward Meyer Cancer Center at Weill Cornell Medicine

    Watch replay
  • image description

    Increasing PTS using multimodal data

    Learn how AstraZeneca employs multimodal data to increase the probability of technical success of all Phase 3 oncology studies.

    Speakers: Iker Huerga
    SVP, Life Sciences Strategy, Tempus

    Leora Horn, MD
    Global Clinical Head for Lung Cancer & Lung Cancer Strategy, AstraZeneca

    Watch replay
  • image description

    Multimodal data drives biomarker innovation

    We spoke with Gilead experts to learn how the company uses multimodal data to achieve early successes in translational biomarker research and discovery.

    Speakers: Ryan Fukushima
    Chief Operating Officer, Tempus

    Scott Patterson, PhD
    Vice President of Biomarker Sciences, Gilead Sciences, Inc.

    Shahed Iqbal, PhD
    Senior Director and Head of Molecular Epidemiology, Biomarker Sciences, Gilead Sciences, Inc.

    Watch replay
  • image description

    The evolving standards of precision medicine: implications of Tempus abstract findings from the 2022 ASCO® Annual Meeting

    Speakers: Ezra Cohen, MD, FRCPSC, FASCO
    Chief, Division of Hematology-Oncology, UC San Diego Moores Cancer Center

    Mary J. Fidler, MD
    Medical Oncology Section Chief, Rush Medical Center

    Wade T. Iams, MD, MSCI
    Assistant Professor of Medicine, Vanderbilt-Ingram Cancer Center

    Calvin Chao, MD
    SVP, Medical Affairs, Tempus

    James L. Chen, MD
    SVP, Cancer Informatics, Tempus

    Watch replay
  • image description

    Personalize mental health with Pharmacogenomics

    In this on-demand webinar, Dr. Brian Forsythe shares how he incorporates PGx testing into clinical practice to inform treatment decisions for patients.

    Speakers: Brian C. Forsythe, D.O.; Dallas Psychiatry & TMS Center, Joseph D. Stanton, PhD - Associate Director, Medical Affairs

    Watch replay
1 2 3